WithdrawnPhase 3NCT04031066

Interventional Study to Assess Efficacy and Safety of Velmanase Alfa in Patients With Alpha Mannosidosis

Studying Alpha-mannosidosis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Chiesi Farmaceutici S.p.A.
Principal Investigator
Paul Harmatz, MD
UCSF Benioff Children's Hospital Oakland
Intervention
Velmanase Alfa(drug)
Eligibility
All sexes
Timeline
2021 – 2021

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04031066 on ClinicalTrials.gov

Other trials for Alpha-mannosidosis

Additional recruiting or active studies for the same condition.

See all trials for Alpha-mannosidosis →

← Back to all trials